GALNS and mucopolysaccharidosis type 4A: GALNS deficiency leads to the accumulation of keratan sulfate and chondroitin 6-sulfate, resulting in skeletal dysplasia and systemic manifestations in MPS IVA patients (Leal et al., 2023).